Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMedOpen access

Muscle-fiber-inspired nanofibrillar microbundles induce myogenic differentiation in human adipose-derived stem cells.

Mussoni C., Heinze C., Ryma M., Jun I., Lamberger Z., Andelovic K.

Laboratory Study on Hip, published in Bioact Mater (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Bioact Mater (2026)
Country
China
Reported sample size
—
Source database
PubMed
PMID
42006000
PMCID
PMC13091133
DOI
10.1016/j.bioactmat.2026.03.020

Abstract (original English)

Skeletal muscle function relies on uniaxially organized myofibers, whose aligned extracellular matrix provides instructive topographical cues that regulate myogenic behavior. Here, we introduce a melt electrofibrillation strategy, melt electrowriting (MEW) of poly (ε-caprolactone)/poly (vinyl acetate) blends, followed by selective polyvinyl acetate removal, to fabricate highly aligned nanofibrillar microbundle scaffolds that present collagen-like nanotopography. We first verified biocompatibility and alignment guidance using primary human skeletal muscle cells compared with 2D tissue culture polystyrene controls. We then assessed the myogenic response of human adipose-derived stem cells (hASCs) on nanofibrillar scaffolds relative to conventional MEW-printed microfibers and 2D controls. Nanofibrils supported sustained viability over 35 days and promoted pronounced cell alignment, aligned collagen type-I deposition, and enhanced myogenic differentiation. hASCs on the scaffolds formed myosin-positive, multinucleated myotube-like structures by days 28-35 and exhibited increased MYOG and MYF6 expression by qPCR. Bulk RNA sequencing (day 21) further showed that nanofibrils induce a distinct transcriptional state enriched for muscle development/differentiation and contraction-associated programs, accompanied by activation of mechanosensitive signaling and adhesion-cytoskeleton remodel

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research